Xponance’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Xponance’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-357	Closed	-$3.25K	–	1310
2023 Q1	$3.25K	Hold	357	–	–	﹤0.01%	1240
2022 Q4	$4.19K	Buy	357 +3	+0.8%	+$53	﹤0.01%	1232
2022 Q3	$8K	Buy	354 +9	+3%	+$243	﹤0.01%	1190
2022 Q2	$8K	Buy	+345	New	+$11.7K	﹤0.01%	1190
2021 Q3	–	Sell	-340	Closed	-$34K	–	1244
2021 Q2	$34K	Buy	+340	New	+$33.1K	﹤0.01%	1235

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Xponance's VBIV Position: Q2 2023 in Review

Xponance sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 357 shares — an estimated $3.25K sold.

Xponance first reported a position in VBIV in Q2 2021 and held it in 5 quarters. The position peaked at $34K in Q2 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

Xponance reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
Xponance sold 357 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $3.25K.
Xponance first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2021 and held it in 5 quarters.
Xponance's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $34K in Q2 2021.
46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on Xponance's 13F filing for Q2 2023, filed 14 Jul 2023.